David M. Iser
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 41
- Hepatitis C virus research 39
- Liver Disease and Transplantation 4
- Epidemiology 24
- Hepatitis B Virus Studies 20
- Liver Disease Diagnosis and Treatment 11
- Co-authors
- A. Thompson (28 shared papers)Paul V Desmond (15 shared papers)Sharon R. Lewin (9 shared papers)Tin Quang Nguyen (6 shared papers)STEPHEN A LOCARNINI (5 shared papers)Edward John Gane (8 shared papers)John Slavin (3 shared papers)Scott Bowden (3 shared papers)
- Journals
- Journal of Gastroenterology and Hepatology (8 papers)Journal of Hepatology (6 papers)Liver International (4 papers)Journal of Viral Hepatitis (3 papers)Antiviral Therapy (3 papers)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
David M. Iser
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 73
- Hepatology 879
- Epidemiology 928
- Virology 54
- Infectious Diseases 112
- Nephrology 34
Countries citing papers authored by David M. Iser
This map shows the geographic impact of David M. Iser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Iser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Iser more than expected).
Fields of papers citing papers by David M. Iser
This network shows the impact of papers produced by David M. Iser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Iser. The network helps show where David M. Iser may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Iser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 363 | |
| 2 | 2015 | 141 | |
| 3 | 2019 | 89 | |
| 4 | 2000 | 78 | |
| 5 | 2015 | 68 | |
| 6 | 2019 | 66 | |
| 7 | 2015 | 45 | |
| 8 | 2010 | 44 | |
| 9 | 2013 | 43 | |
| 10 | 2010 | 43 | |
| 11 | 2006 | 37 | |
| 12 | 2009 | 35 | |
| 13 | 2013 | 33 | |
| 14 | 2022 | 30 | |
| 15 | 2008 | 27 | |
| 16 | 2008 | 26 | |
| 17 | 2014 | 25 | |
| 18 | 2007 | 23 | |
| 19 | Fatty liver disease--a practical guide for GPs. | 2013 | 21 |
| 20 | 2017 | 21 |
About David M. Iser
David M. Iser is a scholar working on Hepatology, Epidemiology, Virology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (39 papers), Hepatitis B Virus Studies (20 papers), Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (4 papers), HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (2 papers), Migration, Health and Trauma (1 paper) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Hepatology (879 citations), Epidemiology (928 citations), Virology (54 citations), Infectious Diseases (112 citations) and Nephrology (34 citations). David M. Iser has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include A. Thompson, Paul V Desmond, Sharon R. Lewin, Tin Quang Nguyen, STEPHEN A LOCARNINI, Edward John Gane, John Slavin, Scott Bowden, Kumar Visvanathan and Joseph Doyle. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Journal of Hepatology, Liver International, Journal of Viral Hepatitis and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.